scholarly article | Q13442814 |
P356 | DOI | 10.1177/1759091415609613 |
P8608 | Fatcat ID | release_sd2kjvcz5vaotg23jhhur7xzgq |
P932 | PMC publication ID | 4710131 |
P698 | PubMed publication ID | 26489686 |
P5875 | ResearchGate publication ID | 283337471 |
P50 | author | Charles L White | Q60638965 |
E. Sally Ward | Q75346560 | ||
Jacqueline R Rivas | Q86532028 | ||
P2093 | author name string | William Robinson | |
Min Li | |||
Ann J Ligocki | |||
Elliot M Frohman | |||
Ding Chen | |||
Edgar Meinl | |||
Ann M Stowe | |||
Nancy L Monson | |||
William H Rounds | |||
Benjamin M Greenberg | |||
Donna Graves | |||
Lauren Lahey | |||
Melania Spadaro | |||
Alyssa A Guzman | |||
Paul M Henson | |||
P2860 | cites work | The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies | Q24316787 |
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain | Q24602799 | ||
Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms | Q26795528 | ||
Multiple sclerosis-a quiet revolution | Q26826930 | ||
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies | Q28282500 | ||
Multiple sclerosis | Q28299151 | ||
The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia | Q28513858 | ||
Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms | Q28587441 | ||
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP | Q29547505 | ||
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
Gray matter damage in multiple sclerosis: Impact on clinical symptoms | Q30979785 | ||
Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library | Q33230101 | ||
Nerve blocks for cutaneous surgery on the foot | Q33560738 | ||
Cortical lesions in multiple sclerosis | Q33631075 | ||
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid | Q33745475 | ||
Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time | Q34073320 | ||
A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis | Q34117793 | ||
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing | Q34193087 | ||
Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein | Q34773444 | ||
Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation. | Q35077861 | ||
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients | Q35744057 | ||
A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity | Q35747637 | ||
A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons. | Q35806036 | ||
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis | Q35986699 | ||
Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. | Q36082102 | ||
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing | Q36433030 | ||
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal | Q36455215 | ||
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning | Q36459907 | ||
The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration | Q36610350 | ||
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs | Q36686295 | ||
Specific peripheral B cell tolerance defects in patients with multiple sclerosis | Q36890946 | ||
The comparative biology of neuromelanin and lipofuscin in the human brain | Q37085791 | ||
Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS | Q37258223 | ||
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. | Q37304222 | ||
Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential | Q37439187 | ||
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. | Q37445439 | ||
Spinal cord gray matter atrophy correlates with multiple sclerosis disability | Q37651386 | ||
Autoantibodies to intracellular antigens: generation and pathogenetic role. | Q37852410 | ||
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity. | Q37995305 | ||
Immunology of relapse and remission in multiple sclerosis | Q38179507 | ||
B cells in MS and NMO: pathogenesis and therapy | Q38212081 | ||
Targets of the humoral autoimmune response in multiple sclerosis | Q38238409 | ||
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica | Q38529196 | ||
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases | Q39353775 | ||
Transplanted neural precursors enhance host brain-derived myelin regeneration | Q39762323 | ||
Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. | Q39786593 | ||
The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography study | Q40622624 | ||
Periventricular lesions correlate with cortical thinning in multiple sclerosis | Q40825942 | ||
Repetitive hypoxia extends endogenous neurovascular protection for stroke | Q41991619 | ||
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. | Q42847184 | ||
The brain-specific Neural Zinc Finger transcription factor 2b (NZF-2b/7ZFMyt1) causes suppression of cocaine-induced locomotor activity | Q43270146 | ||
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis. | Q44403860 | ||
Arginines in the CDR of anti-dsDNA autoantibodies facilitate cell internalization via electrostatic interactions | Q45399598 | ||
Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. | Q45902843 | ||
A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicity | Q47994013 | ||
Intrathecal activation of the complement system and disability in multiple sclerosis | Q47995950 | ||
Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell | Q48063176 | ||
Subpial demyelination in the cerebral cortex of multiple sclerosis patients | Q48233815 | ||
Evidence for progressive gray matter loss in patients with relapsing-remitting MS. | Q48735996 | ||
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis | Q48949365 | ||
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis | Q48949792 | ||
Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. | Q54759503 | ||
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis | Q57767625 | ||
Gray matter atrophy is related to long-term disability in multiple sclerosis | Q61861932 | ||
Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis | Q61861985 | ||
Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro | Q70514588 | ||
Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Qualitative evidence of anti-HuD specific IgG-synthesis in the central nervous system | Q73153784 | ||
Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis | Q74016851 | ||
Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging | Q77486551 | ||
Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice | Q80109125 | ||
Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients | Q81119751 | ||
P433 | issue | 5 | |
P921 | main subject | multiple sclerosis | Q8277 |
relapsing-remitting multiple sclerosis | Q18555066 | ||
P577 | publication date | 2015-09-01 | |
P1433 | published in | ASN Neuro | Q20312578 |
P1476 | title | A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients | |
P478 | volume | 7 |
Q38657074 | Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment. |
Q26770852 | B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation |
Q104479846 | B cell depletion therapies in autoimmune disease: advances and mechanistic insights |
Q30842875 | Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination |
Q37645937 | Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients |
Q93062665 | Single-Cell High-Throughput Technologies in Cerebrospinal Fluid Research and Diagnostics |
Search more.